| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |